Company Overview and News


2018-04-09 globenewswire
Financial statements The AGM approved the parent company financial statements and the consolidated financial statements, and members of the Board of Directors and the President and CEO were discharged from liability for the 2017 financial period.


2018-04-09 globenewswire
Tilinpäätös Yhtiökokous vahvisti emoyhtiön ja konsernin tilinpäätöksen sekä myönsi hallituksen jäsenille ja toimitusjohtajalle vastuuvapauden tilikaudelta 2017.

Reasons Why You Should Hold WestRock in Your Portfolio Now

2018-03-28 zacks
WestRock Company (WRK - Free Report) remains well-poised for growth, backed by its focus on execution of capital allocation strategy and KapStone acquisition. Improving industry conditions and a positive volume along with pricing dynamics are other key growth drivers for the company. However, raw material cost inflation and weak demand for processed foods as well as carbonated drinks remain headwinds.

Domtar Rides on Modest Revenue Growth, Margin Woes Remain

2018-03-26 zacks
On Mar 26, we issued an updated research report on paper & paper products firm, Domtar Corporation (UFS - Free Report) . Domtar is currently seeking growth through profitable investment opportunities with a commitment to pollution-free environment and sustainable practices. The company is also streamlining the cost structure, improving revenue quality and maintaining a healthy cash flow with a disciplined approach to cash utilization.

Warmer Winters Are a Huge Threat to $30 Billion Nordic Industry - Bloomberg

2018-03-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Stora Enso: Fundamental Trends And Momentum Suggest Good Returns

2018-03-09 seekingalpha
Ranking 853 low EV/EBIT stocks on multiple value metrics shows Stora Enso is cheap. Simultaneously it has a good combination of strong and smooth momentum. This predicts good statistical returns.

EU Eyes Billions of Euros From CO2 Market for Post-Brexit Budget - Bloomberg

2018-02-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Stora Enso Oyj's (SEOJF) CEO Karl-Henrik Sundström on Q4 2017 Results - Earnings Call Transcript

2018-02-10 seekingalpha
Good day and welcome to the Q4 2017 Stora Enso Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Ulla Paajanen-Sainio, Head of Investor Relations. Please go ahead, Madam.

Stora Enso Oyj ADR 2017 Q4 - Results - Earnings Call Slides

2018-02-09 seekingalpha
The following slide deck was published by Stora Enso Oyj ADR in conjunction with their 2017 Q4 earnings call.

Stora Enso Oyj 2017 Q4 - Results - Earnings Call Slides

2018-02-09 seekingalpha
The following slide deck was published by Stora Enso Oyj in conjunction with their 2017 Q4 earnings call.

Oil's Dream to Grow in Plastics Dims as Coke Turns to Plants - Bloomberg

2018-01-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Domtar (UFS) Scales 52-Week High on Solid Growth Dynamics

2017-12-27 zacks
Shares of Domtar Corporation (UFS - Free Report) scaled a new 52-week high of $50.20 during yesterday’s trading session, before closing a notch lower at $49.66 for a healthy year-to-date return of 27.2%. Barring minor hiccups, Domtar’s share price has steadily been on an uptrend since mid-August. Notably, this Zacks Rank #2 (Buy) stock has the potential for further price appreciation with long-term earnings growth expectation of 5%.

WestRock (WRK) Set to Acquire Plymouth Packaging's Assets

2017-12-15 zacks
WestRock Company (WRK - Free Report) has entered into agreement to acquire substantially all of the assets of Plymouth Packaging, Inc. The buyout will boost WestRock’s margin performance and growth prospects in corrugated packaging business. The deal will also improve its innovation platform and differentiation strategy. Why Plymouth? Plymouth is a corrugated packaging company that derives approximately 70% of sales from its Box on Demand systems and corrugated fanfold, and 30% from traditional corrugated box packaging.

WestRock (WRK) Hits 52-Week High: What's Driving the Stock?

2017-12-01 zacks
Shares of WestRock Company (WRK - Free Report) scaled a 52-week high of $62.61 on Nov 30, eventually closing lower at $62.41. The gain is driven by WestRock’s solid performance in fiscal 2017, encouraging outlook for fiscal 2018, as well as its focus on acquisitions. The company has a market cap of $15.7 billion. Over the last three months, its average volume of shares traded is approximately 1.5M.

Neenah Paper (NP) Hikes Quarterly Dividend Payout by 11%

2017-11-30 zacks
Neenah Paper, Inc. (NP - Free Report) , a global manufacturer of technical products and fine papers, recently announced an 11% year-over-year hike in its quarterly dividend payout. The new dividend will be 41 cents per share or $1.64 on an annualized basis. It will be payable from first-quarter 2018. Based on the closing price of $89.20 on Nov 29, the proposed dividend affirms a yield of 1.8%. A steady dividend payout is part of the long-term strategy of Neenah to provide attractive risk-adjusted returns to its stockholders.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 86210M106